Reach Neuro
We are an early stage startup developing the first-ever treatment for chronic disability caused by stroke.
About Reach Neuro
Recent Funding lists Reach Neuro under Health and bio. It went through IndieBio (IndieBio SF 13). It was founded by Doug Weber and Marco Capogrosso.
Funding rounds
- X account created
- IndieBio SF 13
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
DW
Doug Weber Founder@dougweberlab · source: x.comMC
Marco Capogrosso Founder@MCapogrosso · source: x.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Reach Neuro: questions and answers
- Who invested in Reach Neuro?
- Investors on record for Reach Neuro: IndieBio.
- Who founded Reach Neuro?
- Reach Neuro was founded by Doug Weber and Marco Capogrosso.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/reach-neuro (get a free API key).